Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Winkles IsabelleChief Financial Officer | Grant or award | A | — 135.2K sh | Mar 20, 2026 |
| 12 | Duffy Kristine DDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Stenberg JonDirector, President & CEO | Tax withholding | F | $55K 11.9K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Dawsey James MDirector | Other acquisition or disposition | J | $14K 453 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Tax withholding | F | $216K 50.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 12 | Morris Philip CDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Herraiz Lizette BenediGENERAL COUNSEL | Open-market sale · 10b5-1 plan | SELL | $238K 2,982 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Antonello Katherine H.Director, President & CEO | Tax withholding | F | $205K 5,258 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Boone Travis JDirector, PRESIDENT & CEO | Tax withholding | F | $109K 10.5K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 12 | Bendza Gary MarkEVP, CFO | Tax withholding | F | $211K 49.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 11 | Dieter DavidEVP & General Counsel | Open-market sale · 10b5-1 plan | SELL | $488K 14.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 125.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 693.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Gessert EricaChief Financial Officer | Option exercise | M | — 9,699 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 32.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 21.2K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 211.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 440.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 211.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | AmundiDirector, 10% Owner | Disposition to issuer | D | — 100.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aulestia Bernadette S.Director | Grant or award | A | — 905 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 176.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 693.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 176.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | You Harry L.Director, 10% Owner | Grant or award | A | — 2.88M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 32.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Shlimak AnnaSee Remarks | Tax withholding | F | $25K 9,767 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Option exercise | M | — 123.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 638.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 543.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 162.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Hyman JonathanChief Technology Officer | Grant or award | A | — 89.6K sh | Mar 20, 2026 traded Mar 18, 2026 |